Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oral Anticoagulation”

193 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 193 results

Not applicableLooking for participantsNCT02219984
What this trial is testing

START-Register: Survey on Anticoagulated Patients Register

Who this might be right for
Atrial FibrillationVenous ThromboembolismHeart Valve Diseases or Prosthesis
GUALTIERO PALARETI 15,410
Testing effectiveness (Phase 2)Active Not RecruitingNCT05006287
What this trial is testing

The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery

Who this might be right for
Atrial Fibrillation
St. Paul's Hospital, Canada 100
Large-scale testing (Phase 3)Study completedNCT00740493
What this trial is testing

Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP)

Who this might be right for
Recurrent Venous ThromboembolismIdiopathic Deep Vein Thrombosis
University Hospital, Brest 104
Not applicableEnded earlyNCT02793895
What this trial is testing

Detection of Atrial Fibrillation After Cardiac Surgery

Who this might be right for
Atrial FibrillationAtrial FlutterC.Surgical Procedure; Cardiac+1 more
Unity Health Toronto 336
Not applicableLooking for participantsNCT06556446
What this trial is testing

Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants

Who this might be right for
Ischemic Stroke
Insel Gruppe AG, University Hospital Bern 2,800
Large-scale testing (Phase 3)Ended earlyNCT02618577
What this trial is testing

Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes

Who this might be right for
Atrial High Rate Episodes
Atrial Fibrillation Network 2,608
Post-approval studies (Phase 4)Study completedNCT02161965
What this trial is testing

Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation

Who this might be right for
Permanent Atrial FibrillationVenous ThrombosisPulmonary Embolism+1 more
University Hospital, Angers 51
Post-approval studies (Phase 4)Study completedNCT00603317
What this trial is testing

Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic Acid

Who this might be right for
Oral AnticoagulationDeep Venous ThrombosisAtrial Fibrillation+1 more
Assistance Publique - Hôpitaux de Paris 13
Large-scale testing (Phase 3)Study completedNCT00794755
What this trial is testing

Low Dose Supplementation to Improve Anticoagulation Control With Oral Vitamin K as an Adjuvant to Warfarin Therapy

Who this might be right for
Coagulation
Ottawa Hospital Research Institute 100
Large-scale testing (Phase 3)Looking for participantsNCT04284839
What this trial is testing

The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial

Who this might be right for
Bleeding Post Cardiac SurgeryIndication for Anticoagulation
Population Health Research Institute 3,500
Large-scale testing (Phase 3)Study completedNCT00423319
What this trial is testing

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Bristol-Myers Squibb 5,407
Large-scale testing (Phase 3)Looking for participantsNCT03243175
What this trial is testing

Avoiding Anticoagulation After IntraCerebral Haemorrhage

Who this might be right for
Intracerebral HemorrhageAtrial FibrillationMicrohaemorrhage
University Hospital, Lille 300
Large-scale testing (Phase 3)Looking for participantsNCT04066764
What this trial is testing

Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

Who this might be right for
Venous Thromboembolism
Second Affiliated Hospital, School of Medicine, Zhejiang University 200
Not applicableLooking for participantsNCT03642509
What this trial is testing

Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation

Who this might be right for
Atrial FibrillationStroke
University of Aarhus 750
Not applicableStudy completedNCT03532724
What this trial is testing

Clinical Outcomes From Patient Self-management of Antivitamin K Treatment

Who this might be right for
Self Management of Oral Anticoagulation With VKA Therapy
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 927
Post-approval studies (Phase 4)UnknownNCT04981041
What this trial is testing

Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI

Who this might be right for
Acute Coronary SyndromeAtrial Fibrillation
Ludwig-Maximilians - University of Munich 2,334
Not applicableUnknownNCT01339611
What this trial is testing

Education Program for Patients Receiving Oral Anticoagulation

Who this might be right for
Cardiovascular DiseaseVenous ThrombosesAtrial Fibrillation+1 more
University of Sao Paulo 160
Not applicableStudy completedNCT03292666
What this trial is testing

Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study

Who this might be right for
Venous ThromboembolismAnticoagulants and Bleeding Disorders
University of California, San Francisco 39,603
Testing effectiveness (Phase 2)UnknownNCT05233124
What this trial is testing

Antithrombotic Therapy in Acute Coronary Syndromes and Coronary Artery Ectasia

Who this might be right for
Acute Coronary SyndromeCoronary Artery Ectasia
Instituto Nacional de Cardiologia Ignacio Chavez 60
Post-approval studies (Phase 4)Looking for participantsNCT04437654
What this trial is testing

The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)

Who this might be right for
Atrial Fibrillation Patients With Intermediate Stroke Risk
Yonsei University 1,800
Load More Results